MAFM
GILD icon

Mid Atlantic Financial Management’s Gilead Sciences GILD Stock Holding History

Mid Atlantic Financial Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$466K Sell
6,669
-474
-7% -$33.3K 0.03% 474
2021
Q2 		$492K Sell
7,143
-25
-0.3% -$1.67K 0.03% 469
2021
Q1 		$463K Sell
7,168
-501
-7% -$32.3K 0.03% 458
2020
Q4 		$447K Buy
7,669
+348
+5% +$21K 0.03% 426
2020
Q3 		$432K Sell
7,321
-5,062
-41% -$351K 0.04% 395
2020
Q2 		$953K Sell
12,383
-411
-3% -$31.5K 0.09% 198
2020
Q1 		$956K Sell
12,794
-2,970
-19% -$205K 0.11% 169
2019
Q4 		$1.02M Buy
15,764
+1,813
+13% +$118K 0.1% 212
2019
Q3 		$884K Sell
13,951
-2,250
-14% -$147K 0.09% 229
2019
Q2 		$1.09M Sell
16,201
-560
-3% -$36.8K 0.11% 174
2019
Q1 		$1.09M Buy
16,761
+1,356
+9% +$90.1K 0.12% 166
2018
Q4 		$964K Buy
+15,405
New +$1.08M 0.12% 163

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mid Atlantic Financial Management's GILD Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its Gilead Sciences (GILD) stake by 6.6% in Q3 2021, selling an estimated $33.3K and leaving 6,669 shares worth $466K. The position accounts for 0.03% of the portfolio, ranked #474.

Mid Atlantic Financial Management first reported a position in GILD in Q4 2018 and has held it in 12 quarters since. The position peaked at $1.09M in Q2 2019. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Mid Atlantic Financial Management held 6,669 shares of Gilead Sciences worth $466K as of Q3 2021.
  • Mid Atlantic Financial Management sold 474 Gilead Sciences shares in Q3 2021, an estimated $33.3K.
  • Gilead Sciences made up 0.03% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #474 holding.
  • Mid Atlantic Financial Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 12 quarters since.
  • Mid Atlantic Financial Management's Gilead Sciences position peaked at $1.09M in Q2 2019.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.